Research Articles
AI and the Designer Drug Arms Race: How Algorithms Are Creating—and Combating—New Psychoactive Substances
Exploring how artificial intelligence is revolutionizing the creation and detection of new psychoactive substances in a high-stakes digital battle.
When Metabolites Become Drugs: The Curious Case of Designer Benzodiazepines
Exploring the science behind fonazepam and nifoxipam - designer benzodiazepines that originated as active metabolites of flunitrazepam
The Silent Evidence: Tracking Designer Drugs in the Body's Clues
How cutting-edge science is winning the race against new synthetic drugs through novel extraction methods and GC-MS analysis.